Related Experiment Video
Updated: Sep 9, 2025

06:39
Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
3.1K
Bacterial Extracellular Vesicles: Emerging Regulators in the Gut-Organ Axis and Prospective Biomedical Applications
Bingqi Zhang1, Mingyan Liu1, Lingxin Jiang1
1School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Current Microbiology
|September 1, 2025
Summary
Bacterial extracellular vesicles (BEVs) from gut microbes carry signals influencing health across organ systems. This review details BEV roles in gut-organ axis diseases and their diagnostic and therapeutic potential.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Gut microbiota metabolites critically influence host health.
- Bacterial extracellular vesicles (BEVs) are emerging as key mediators of microbial-host interactions.
- BEVs transport bioactive substances and signaling molecules, impacting various physiological processes.
Purpose of the Study:
- To systematically review the biogenesis of bacterial extracellular vesicles (BEVs).
- To elucidate the regulatory roles of BEVs in gut-organ axis diseases.
- To explore the diagnostic and therapeutic applications of BEVs.
Main Methods:
- Systematic literature review.
- Analysis of existing research on BEV biogenesis and function.
- Exploration of potential applications in disease diagnosis and prevention.
Main Results:
- BEVs play significant roles in the gut-organ axis, affecting the central nervous system, kidneys, liver, bones, lungs, cardiovascular system, and metabolism.
- BEVs are involved in intercellular communication and modulation of host immune responses.
- The composition and function of BEVs are influenced by bacterial species and host environment.
Conclusions:
- Bacterial extracellular vesicles (BEVs) are crucial mediators in gut-host crosstalk, impacting multiple organ systems.
- BEVs hold significant promise for the development of novel diagnostic biomarkers and therapeutic strategies.
- Further research into BEV biology will facilitate the creation of innovative tools for disease management.
Related Concept Videos
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Intralumenal Vesicles and Multivesicular Bodies
3.7K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.7K

